Novel PET Agent Detects Multiple Cancers, IDs Patients for Targeted Therapies
A new PET agent can diagnose various cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies.
Category: Nuclear Medicine
Nuclear Medicine
Latest
Nuclear Medicine
Latest
Jersey Shore University Medical Center Adds Advanced Technology to Detect Movement Disorders
Hackensack Meridian Jersey Shore University Medical Center Neuroscience Institute recently added a new diagnostic imaging system.
Nuclear Medicine
Latest
USTW Clinical Trial Sets Stage for New Paradigm in Kidney Cancer Treatment
Stereotactic ablative radiation controls oligometastatic kidney cancer while preserving patient quality of life, UT Southwestern study finds.
New PET Agent Highly Effective for Imaging Meningiomas
A novel somatostatin-receptor targeting peptide—18F-SiTATE—has been shown to provide excellent imaging in patients with meningiomas.
Read More
Targeted Radionuclide Alpha Therapy Improves Prostate Cancer Outcomes
Study results demonstrate the potential of 225AC-NM600 for the treatment of advanced-stage prostate cancer patients.
Read More
PET Imaging Confirms Link Between Obstructive Sleep Apnea and Heart Blood Flow Impairment
Patients with severe obstructive sleep apnea are less able to increase blood flow to the heart when needed, according to a PET imaging study.
Read More
PET/CT Effective in Evaluating and Monitoring Post-COVID-19 Lung Disease
PET/CT has been proven successful in evaluating lung inflammation and monitoring treatment in patients with post-COVID-19 lung disease.
Read More
Siemens Healthineers SPECT/CT Scanner Nets FDA Clearance
Siemens Healthineers announces that the U.S. FDA has cleared the Symbia Pro.specta, an advanced SPECT/CT system that offers a low-dose CT of up to 64 slices.
Read More